packageCeritinib

ceritinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Ceritinib is an ALK inhibitor used to treat non-small-cell lung cancer. It is an approved medicine, authorised in the European Union for this indication.

Summary written by glm-5.3-flash from Wikidata Q21011233 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:ceritinib
ATC codes:L01ED02, L01XE
DrugBank:DB09063
PubChem CID:57379345
ChEBI:78432
Wikidata:Q21011233
formula:C28H36ClN5O3S
molar mass:558.138 g/mol (PubChem CID 57379345)
logP:6.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown